DS, B., DN, A., SR, A., IN, V., IG, B., NV, B., . . . JP, G. (2026). Effectiveness and Safety of First-Line Empirical Eradication Therapy with Rebamipide: Results from the European Registry on Helicobacter pylori Management (Hp-EuReg). Antibiotics (Basel, Switzerland), 15(6), . https://doi.org/10.3390/antibiotics15060531
Chicago Style (17th ed.) CitationDS, Bordin, et al. "Effectiveness and Safety of First-Line Empirical Eradication Therapy with Rebamipide: Results from the European Registry on Helicobacter Pylori Management (Hp-EuReg)." Antibiotics (Basel, Switzerland) 15, no. 6 (2026). https://doi.org/10.3390/antibiotics15060531.
MLA (9th ed.) CitationDS, Bordin, et al. "Effectiveness and Safety of First-Line Empirical Eradication Therapy with Rebamipide: Results from the European Registry on Helicobacter Pylori Management (Hp-EuReg)." Antibiotics (Basel, Switzerland), vol. 15, no. 6, 2026, https://doi.org/10.3390/antibiotics15060531.